Highlights of the 2016 ARVO Annual Meeting
Select research findings presented this year.
By Sze H. Wong, MD, and Albert S. Khouri, MD
The Literature By Leonard K. Seibold, MD; Malik Y. Kahook, MD; and Jeffrey R. SooHoo, MD
What Is the Real IOP?
Laboratory studies may help us better understand our clinical dilemmas.
By Dan Eisenberg, MD
The Literature By Reena A. Garg, MD, and Helen Jiang, MD
Detecting and Treating Glaucoma in a Myopic Patient Without High IOP By Robert Chang, MD, and Kuldev Singh, MD, MPH
The Eyes of Africa Project
Partners bring comprehensive eye care to rural Malawi.
By William Eric Sponsel, MD
Assessing Corneal Biomechanics
The importance of these properties rests primarily with their effects on IOP measurement.
By Leon W. Herndon, MD
Evaluating Quality of Life in Glaucoma
Understand the impact of the disease to improve care.
By Felipe A. Medeiros, MD, PhD
Do We Need Perimetry?
As glaucoma advances, visual field testing provides valuable insight.
By Murray Fingeret, OD
Enhancing Visual Field Testing
Techniques to increase the value and reliability of visual fields.
By Oluwatosin Smith, MD
The Role of Optic Nerve Head Imaging
Past, present, and future.
By Anitra Turner, MD, and Anjali Bhorade, MD, MSCI
Optical Coherence Tomography as a Glaucoma Screening Tool
Does it affect glaucoma detection in the community?
By Lisa F. Rosenberg, MD, and Casey Cahill, MD
Is There Still a Role for Optic Disc Photography?
New is not necessarily better.
By George L. Spaeth, MD; Kamran Rahmatnejad, MD; and Lichuan Zeng, BSE
Fighting Side by Side By Sze H. Wong, MD
Down, But Not Out: How the AAO Has Responded to Medicare's 2016 Ophthalmology Fee Cuts
Faced with cuts to ophthalmic reimbursements, the American Academy of Ophthalmology sprang into action.
By George A. Williams, MD
The Literature By Alex S. Huang, MD, PhD, and Alan T. Begian
What Is the Real IOP?
How laboratory glaucoma studies may help us better understand this clinical dilemma.
By Nathan Radcliffe, MD
Screening the Future By Avni Shah, MD
Why I Perform Research in a Clinical Practice
Participating in clinical research provides new options for my patients and growth opportunities for my practice.
By Gregory D. Parkhurst, MD
Highlights of the AGS Annual Meeting
The latest research findings from the 26th annual meeting of the American Glaucoma Society, held March 3 to 6, 2016, in Fort Lauderdale, Florida.
By Geoffrey T. Emerick, MD
Rho Kinase/Norepinephrine Transporter Inhibition for the Treatment of Glaucoma and Ocular Hypertension
An update on the clinical development of a new class of drugs.
By Jason Bacharach, MD
Tools of the Tube Trade By Jonathan S. Myers, MD
The Literature By Andrew Garcia, MD, and Christopher C. Teng, MD
Addressing Poor Adherence By Larissa Habib, MD
Is the Grass Really Greener on the Other Side?
The pros and cons of ophthalmology business models.
By Richard A. Lehrer, MD
Dealing With Reimbursement Cuts
Two surgeons share their strategies.
By Paul F. Palmberg, MD, PhD, and Jeffrey A. Kammer, MD
Benchmarking and the Power of No
Focus, not multitasking, is needed.
By Sean Rochelle
Update on Sustained-Release Drug Therapies
These therapies have the potential to change the glaucoma treatment paradigm.
By Jonathan S. Myers, MD, and Scott J. Fudemberg, MD
S or C Corporation?
Maximize tax deductions by using both.
By Carole C. Foos, CPA, and David B. Mandell, JD, MBA
SIGS: a Simple Surgical Approach to Trabeculectomy By Yuri McKee, MD
Lose the Cape By Steven D. Vold, MD, Chief Medical Editor
The Literature By Paul Lee, MD
Implications for canal-based surgery.
By Haiyan Gong, MD, PhD
Ab Interno Canaloplasty
A minimally invasive and maximally effective glaucoma treatment.
By Mahmood A. Khaimi, MD
Advances in Ophthalmologic Imaging
The current state of optical coherence tomography in glaucoma and the technology’s future applications.
By Scott Butikofer, MD; Kevin Pikey, DO; and Rohit Krishna, MD
The Phase 3 Pipeline
Glaucoma drugs in the works.
By Douglas J. Rhee, MD, and Emily Ahadizadeh, BS
Sidebar: My Experience With a Dual-Blade Device By Leonard K. Seibold, MD
Glaucoma Research in India
Although Indian ophthalmologists author many studies, the sheer volume of patients in the face of limited resources challenges most clinicians’ ability to devote much time to research.
By Subhabrata Chakrabarti, PhD, and Chandra S. Garudadri, MD